SuperworthCoherus Oncology market cap CHRS
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $156M
- Highest close in our data
- $1.6B
- Feb 2020
Coherus Oncology is worth $156M at the close on Oct 23, 2026, at $1.01 a share.
That is down 19% over the last year and down 88% over five years.
Its highest close in our data was $1.6B in Feb 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $156M | $153M | $296.8M | −3% |
| 2025 | $160.8M | $86.2M | $195.3M | −6% |
| 2024 | $171.7M | $83.3M | $319.6M | −54% |
| 2023 | $370.8M | $177.1M | $812.8M | −40% |
| 2022 | $616M | $487.8M | $1.1B | −50% |
| 2021 | $1.2B | $985.5M | $1.4B | −2% |
| 2020 | $1.3B | $977.4M | $1.6B | −2% |
| 2019 | $1.3B | $589.8M | $1.6B | +110% |
| 2018 | $607.5M | $547.6M | $1.4B | +19% |
| 2017 | $509.9M | $483.8M | $1.2B | −59% |
| 2016 | $1.2B | $515.7M | $1.3B | +38% |
| 2015 | $893M | $526.1M | $1.4B | +71% |
| 2014 | $521.5M | $424.4M | $521.5M | n/a |
Against its peers
Companies in Healthcare nearest Coherus Oncology's size, closest first, today.
| Company | Market cap |
|---|---|
| CHRSCoherus Oncology | $156M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| KEQUKewaunee Scientific | $94.9M |
| ICCCImmucell | $93.1M |
| INFUInfuSystem | $277.6M |
| LFVNLifevantage | $73.4M |
| VMDViemed Healthcare | $373.3M |
| Peer median | $209.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Coherus Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.